Promising pharmacological therapies include anti-amyloid-β, anti-tau, anti-oxidative, and anti-inflammatory strategies, but lifestyle-based prevention trials, e.g., healthy diet, resulted in cognitive improvement in people with an increased risk of dementia and the slower development of AD [3,4,5]. Here, MAPT is linked to Alzheimer disease.